State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 210093, China.
Jiangsu Key Laboratory for Nano Technology, Nanjing University, 22 Hankou Road, Nanjing 210093, China.
Mol Pharm. 2023 Sep 4;20(9):4373-4386. doi: 10.1021/acs.molpharmaceut.3c00289. Epub 2023 Aug 14.
Ischemia or hypoxia can lead to pathological changes in the metabolism and function of tissues and then lead to various diseases. Timely and effective blood resuscitation or improvement of hypoxia is very important for the treatment of diseases. However, there is a need to develop stable, nontoxic, and immunologically inert oxygen carriers due to limitations such as blood shortages, different blood types, and the risk of transmitting infections. With the development of various technologies, oxygen carriers based on hemoglobin and perfluorocarbon have been widely studied in recent years. This paper reviews the development and application of hemoglobin and perfluorocarbon oxygen carriers. The design of oxygen carriers was analyzed, and their application as blood substitutes or oxygen carriers in various hypoxic diseases was discussed. Finally, the characteristics and future research of ideal oxygen carriers were prospected to provide reference for follow-up research.
缺血或缺氧会导致组织代谢和功能发生病理变化,进而引发各种疾病。及时有效地进行血液复苏或改善缺氧对于疾病的治疗非常重要。然而,由于血液短缺、不同血型以及感染传播的风险等限制,需要开发稳定、无毒且免疫惰性的氧载体。随着各种技术的发展,近年来基于血红蛋白和全氟化碳的氧载体得到了广泛研究。本文综述了血红蛋白和全氟化碳氧载体的发展和应用。分析了氧载体的设计,并讨论了它们作为血液替代品或在各种缺氧性疾病中的氧载体的应用。最后,展望了理想氧载体的特点和未来研究方向,为后续研究提供参考。